Loading...
ELCC congress 20192025-01-28T17:14:45+01:00

ELCC 2019 – Geneva

Lecture Board: Anne-Marie Dingemans, MD, PhD; Pilar Garrido, MD, PhD; Maximilian Hochmair, MD; Nir Peled, MD, PhD
Medical Writer: Dr. Judith Moser

DOWNLOADS

All downloads from ELCC 2019

ELCC 2019 English

Full report (english)

ELCC 2019 Mandarin

Full report (mandarin)

ELCC 2019 Japanese

Full report (japanese)

EXPERT VIDEOS

All video interviews from ELCC 2019

Pilar Garrido gives an overview of the management of patients with stage III NSCLC, novel treatments in stage III disease and recent insights concerning immune modulatory vaccination in patients with NSCLC.

Thomas Newsom-Davis on the treatment algorithm for ALK-positive NSCLC and future developments for patients with ALK/ROS1-positive tumors.

Nir Peled talks about the importance of early detection of lung cancer – especially in poorer countries –, promising biomarkers for the early detection and new insights into the interactions between lung cancer cells and the tumor microenvironment.

Nir Peled talks about the importance of early detection of lung cancer – especially in poorer countries –, promising biomarkers for the early detection and new insights into the interactions between lung cancer cells and the tumor microenvironment.

At this year’s conference, which took place in Geneva from 10th to 13th April, more than 120 speakers shared their knowledge with around 1,600 delegates from 75 countries. The comprehensive program that included a wide range of session types and the presentation of 210 abstracts aimed at conveying a broad view of the current knowledge ranging from screening and the very early disease to current and potential future treatment approaches for different types of thoracic tumors.

Pilar Garrido • MD • PhD, Head of the Thoracic Tumor Section, Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
Go to Top